上海先鋒控股(01345.HK)與Swiss Health & bioBeauty AG正式簽署經銷協議
格隆匯12月27日丨上海先鋒控股(01345.HK)公吿,近日,上海先鋒控股有限公司及其附屬公司("集團")與一家總部位於瑞士蘇黎世的健康管理公司Swiss Health & bioBeauty AG正式簽署經銷協議。據此,集團將取得其所有的NIANCE(妮瑞斯)品牌("NIANCE")護膚及保健系列產品於中華人民共和國獨家分銷權。
NIANCE由Rainer W. Schmidt(瑞納•施密德)創立,主要包括護膚產品及保健產品。集團認為,隨着護膚、抗衰理念的滲透及悦己理念的強化,以及消費者對於產品效能需求的多元化與專業化,中國的護膚品市場將進入以品質為核心的高質量發展階段。集團希望憑藉NIANCE系列產品具備的出色功效與先進科技,為中國消費者提供更佳體驗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.